Jubilee Clinical Research, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Jubilee Clinical Research, Inc. - overview

Established

2017

Location

Las Vegas, NV, US

Primary Industry

Biotechnology

About

Founded in 2017 by founder Elliot Shin and based in Nevada, US, Jubilee Clinical Research, Inc. engages in conducting clinical trials for various diseases such as asthma, respiratory diseases, diabetes, skin infections, and metabolic syndromes. In September 2024, Pinnacle Clinical Research, LLC/South Texas Research Institute, LLC, a portfolio company of Abacus Finance and LongueVue Capital, acquired Jubilee Clinical Research, Inc. Jubilee Clinical Research offers a variety of services designed to assist with clinical trial management, including patient recruitment, study coordination, and data analysis.


Additionally, Jubilee Clinical provides a platform for sponsors and healthcare professionals to work together on the planning, execution, and analysis of clinical studies. The company is involved in studies across multiple clinical indications, such as neurology, cardiology, and oncology.


Current Investors

Pinnacle Clinical Research, LLC/South Texas Research Institute, LLC

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Healthcare, Pharmaceutical Research & Development

Website

www.jcr-lv.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Jubilee Clinical Research, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedJubilee Clinical Research, Inc.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.